Request Covid 19 Impact
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
“Global Albumin Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global albumin market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global albumin market report has been segmented on the basis of product, application, end user, and region.
Albumin is a protein made by the liver and it makes about 60% of the total protein in blood and plays many roles in body. Albumin keeps fluid from leaking out of blood vessels it nourishes tissues and transports hormones, vitamins, drugs, and substances like calcium throughout the body with help of blood. During certain surgeries, albumin solutions sometimes need to be replace albumin lost during the procedure. Albumin solutions may be used before blood transfusions in the treatment of newborn hemolytic disease. Albumin is injected into a vein in the arm and is always given under direct supervision of a doctor, usually in a hospital or clinic setting. The dose and rate at which the medication is given varies according to individual needs for plasma albumin.
Increasing prevalence of chronic disorders such as liver diseases, infections, and cardiac surgeries resulting into hypoalbuminemia is a major factor driving growth of the global market. In addition, rising adoption of albumin products from the developed countries for non-therapeutic application and increasing awareness related to recombinant albumin are some other factors expected to support growth of the market to certain extent.
Furthermore, changing lifestyle pattern and increasing adoption of albumin for treatment of acute nephrosis are some other factors expected to support growth of the global market.
However, stringent governmental regulations and post-operative risks associated with albumin-based therapy is a major factor expected to hamper growth of the market to certain extent.
Technological advancements and increasing R&D activities by major players is expected to create new opportunities in terms of revenue for player operating in the global market over the forecast period. In addition, development of cost-effective therapeutics coupled with production of albumin on large scale and high potential in untapped markets in the emerging economies are expected to create lucrative opportunities for players in the target market.
The market in North America is expected to dominate the global market in terms of revenue and is expected to continue its dominance over the forecast period. This dominance can be attributed to well-developed healthcare sector and presence of major players operating in the countries in this region. In addition, growing merger and acquisition activities among regional and international players is expected to further support growth of the market to certain extent in this region. The market in Asia Pacific is expected to witness faster growth, owing to increasing government expenditure in pharmaceutical sector, growing public and private partnership for R&D activities and development of innovative products in the emerging economies in this region. The market in Europe is expected to contribute significant revenue share in the global market.
Global Albumin Market Segmentation:
- Human Serum Albumin
- Bovine Serum Albumin
- Recombinant Albumin
- Therapeutics and Diagnostics
- Drug Delivery
- Vaccine Ingredient
- Culture Medium Ingredient & Stabilizer
- In-vitro Fertilization
By End User:
- Pharmaceutical & Biotechnology Industry
- Research Institutes
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Behring LLC
- HiMedia Laboratories Pvt. Ltd.
- Albumedix A/S
- Grifols International S.A.
- Albumin Therapeutics, LLC
- RayBiotech, Inc.
- Octapharma AG
- Sigma-Aldrich Co.
- SeraCare Life Sciences, Inc.
Request for TOC
Don't just take our word. We are trusted by these great companies!